BioSpace News Archive

Adial Pharmaceuticals, Inc. today announced patent number 11957664 was issued April 16, 2024 by the United States Patent and Trademark Office.

NeuroSense Therapeutics Ltd. announced today a collaboration in Alzheimer’s Disease (AD) drug development with Genetika+ , a leader in precision medicine for psychiatry and neurology.

Cidara Therapeutics, Inc. today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-20.

VIVUS LLC announced it has entered into a strategic partnership with UpScriptHealth, a leading, nationwide, direct-to-consumer telemedicine company.

Exactech announced today that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent #11,944,365 and #11,950,820, fortifying the company’s intellectual property and protection around its novel Newton® soft tissue balancing technology for total knee replacement surgery.

Immunovia updates its financial calendar for 2024.

ImmunoPrecise Antibodies Ltd. has recently announced an expansion of its already successful LENSai TM Platform.

Tiziana Life Sciences, Ltd. today announced additional positive clinical results from its intermediate sized Expanded Access Program (EAP) for non-active secondary progressive multiple sclerosis (na-SPMS) patients.

Bristol Myers Squibb and Cellares, the first Integrated Development and Manufacturing Organization dedicated to clinical and industrial-scale cell therapy manufacturing, announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies in a transaction valued up to $380M in upfront and milestone payments.

Centessa Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) to initiate a Phase 1 first-in-human, clinical trial of ORX750 for the treatment of narcolepsy.